Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Guardant Health, Inc.
Report date March 01, 2024 · Filed March 04, 2024
Section 16 reporting ended · disclosed 2024-03-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,475 |
Ending reported balance
After 2024-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-03-01 · Exercise / conversion · Acquired 158 · Balance 27,540 Row 2 · 2024-03-01 · Tax withholding · Disposed 65 · Balance 27,475 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 947 |
Reported balance
After 2024-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-03-01 · Exercise / conversion · Disposed 158 · Balance 947 F2: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2022 Filed Aug 15, 2022 21:59 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 4,500 | $53.38 | $240,224.40 |
DisclosureSEC source: 0001576280-22-000067 · wf-form4_166059806802285.xml · nonDerivative · entry 2 Merrill Amelia · CIK 0001927740 · SVP, People 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,708 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $53.32 to $53.53, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 21:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 5,000 | $4.18 | $20,900.00 |
DisclosureSEC source: 0001576280-22-000067 · wf-form4_166059806802285.xml · nonDerivative · entry 1 Merrill Amelia · CIK 0001927740 · SVP, People 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Sep 13, 2022 20:09 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 1,371 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000077 · wf-form4_166309973925943.xml · derivative · entry 9 Merrill Amelia · CIK 0001927740 · SVP, People 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,371 Underlying: COMMON STOCK · 1,371 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award annually commencing on August 1, 2019. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| August 01, 2022 Filed Sep 13, 2022 20:09 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 475 | $48.38 | $22,980.50 |
DisclosureSEC source: 0001576280-22-000077 · wf-form4_166309973925943.xml · nonDerivative · entry 2 Merrill Amelia · CIK 0001927740 · SVP, People 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,104 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| August 01, 2022 Filed Sep 13, 2022 20:09 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 1,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000077 · wf-form4_166309973925943.xml · nonDerivative · entry 1 Merrill Amelia · CIK 0001927740 · SVP, People 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.